뉴트리코어
US$ 20.03
melanotan dosierung II | Melanocyte Research Peptide Melanotan 2: Safety, Risks &
Description
Pharmacological c-Jun NH2-Terminal Kinase (JNK) pathway inhibition reduces severity of spinal muscular atrophy disease in mice
This is particularly relevant during periods of caloric deficit or increased physical activity, where the demand for energy from fat sources is higher
Dosage optimal : 500 mg / glules
[CrossRef] [PubMed] 7
And this can jumpstart the progression to the possible development of melanoma. Previous case reports have shown some Melanotan-II users develop skin-based complications, including melanoma, however the evidence is still limited
